RNA Interference With Zilebesiran for Mild to Moderate Hypertension
This phase 2 randomized trial examines the antihypertensive efficacy and safety of different zilebesiran dosing regimens.
This phase 2 randomized trial examines the antihypertensive efficacy and safety of different zilebesiran dosing regimens.
As generative AI develops so quickly, regulating it and protecting people has become a challenge.
Objectives To replicate previous analyses on the effectiveness of the English human papillomavirus (HPV) vaccination programme on incidence of cervical cancer and grade 3 cervical…
Common myths about ADHD can spread misinformation about ADHD symptoms and who it affects. A pediatric behavioral health specialist sets the record straight.
Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with…
The advent of neuro-symbolic AI will redefine legal research and analysis, offering unparalleled precision and depth.
Increased global temperature is associated with a wide range of health risks, which are disproportionately high for certain populations. Individual- and population-level measures can reduce…
The meta-analysis examines the use of anticoagulation vs antiplatelet therapy reported in randomized clinical trials on patients with cervical artery dissection.
Dr. Daniel Kraft, Tech Nation Health Chief Correspondent discusses the gap between medical innovation and its adoption into standard practice. He highlights that it typically…
Study identifies 618 proteins linked to 19 different types of cancer, which could lead to much earlier detection of disease
Glycosylation is described as a non-templated biosynthesis. Yet, the template-free premise is antithetical to the observation that different N-glycans are consistently placed at specific sites.…